Correlation Between Artelo Biosciences and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artelo Biosciences and Vaccinex, you can compare the effects of market volatilities on Artelo Biosciences and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Vaccinex.

Diversification Opportunities for Artelo Biosciences and Vaccinex

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Artelo and Vaccinex is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Vaccinex go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Vaccinex

Given the investment horizon of 90 days Artelo Biosciences is expected to under-perform the Vaccinex. But the stock apears to be less risky and, when comparing its historical volatility, Artelo Biosciences is 1.55 times less risky than Vaccinex. The stock trades about 0.0 of its potential returns per unit of risk. The Vaccinex is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  374.00  in Vaccinex on August 29, 2024 and sell it today you would lose (5.00) from holding Vaccinex or give up 1.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Artelo Biosciences  vs.  Vaccinex

 Performance 
       Timeline  
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Artelo Biosciences and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artelo Biosciences and Vaccinex

The main advantage of trading using opposite Artelo Biosciences and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Artelo Biosciences and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments